Mehta, P. and Chandran, V. (2025) “IL-17 Inhibition vs IL-23 Inhibition for Psoriatic Arthritis: An Ongoing Debate”, Canadian Rheumatology Today. Toronto, Canada, 2(2), pp. 4–14. doi: 10.58931/crt.2025.2262.